Ftse Mib
33.089,72
-0,23%
DAX
19.261,75
-0,22%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
96.026,57
0,05%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spruce Biosciences Inc (SPRB) Spruce Biosciences Inc (SPRB) Notizie

SPRB

Spruce Biosciences (SPRB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPRB
DataOraFonteTitoloSimboloCompagnia
14/11/202423:45Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
12/11/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
11/11/202414:00Business WireSpruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
28/10/202421:01Business WireSpruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation ConferenceNASDAQ:SPRBSpruce Biosciences Inc
03/09/202422:01Business WireSpruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:SPRBSpruce Biosciences Inc
12/08/202422:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
12/08/202422:01Business WireSpruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
06/06/202414:00Business WireSpruce Biosciences Recognized as a Bay Area Best Place to WorkNASDAQ:SPRBSpruce Biosciences Inc
05/06/202401:27Business Wireスプルース・バイオサイエンスとHMNC Brain Health GmbH、大うつ病性障害（MDD）の治療法開発に向けた戦略的協働を発表NASDAQ:SPRBSpruce Biosciences Inc
04/06/202422:16Business WireSpruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) anNASDAQ:SPRBSpruce Biosciences Inc
04/06/202422:16Business WireSpruce Biosciences et HMNC Brain Health annoncent une collaboration stratégique pour le développement d’un traitement du trouble dépressif majeur (TDM)NASDAQ:SPRBSpruce Biosciences Inc
04/06/202413:00Business WireSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)NASDAQ:SPRBSpruce Biosciences Inc
03/06/202413:00Business WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
24/05/202422:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
23/05/202422:05Business WireSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/05/202422:14Business WireSpruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyNASDAQ:SPRBSpruce Biosciences Inc
13/05/202422:01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
01/05/202422:05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
30/04/202422:05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
22/04/202422:05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
13/03/202421:08Business WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
13/03/202421:01Business WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
07/03/202422:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
06/02/202422:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
30/01/202422:05Business WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/01/202414:00Business WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
05/01/202414:00Business WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
04/01/202414:00Business WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
13/11/202322:05Business WireSpruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
02/11/202321:05Business WireSpruce Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPRB

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
TEN
Tenaris
BIT
G
Generali
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
MONC
Moncler
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network